Fusion Pharmaceuticals

Fusion Pharmaceuticals in its $212.5 million IPO

Client

Fusion Pharmaceuticals

Value

$212.5 million

Service

Emerging and High Growth Companies

Date Closed

Industry

Health

Lead Office

Toronto


 

On June 25, 2020, Fusion Pharmaceuticals announced the pricing of its initial public offering of 12,500,000 common shares at a public offering price of $17.00 per share. All of the shares are being offered by Fusion. The gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Fusion, are expected to be $212.5 million.

Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines. Employing a proprietary Fast-Clear linker technology, Fusion connects alpha particle emitting isotopes to antibodies and other targeting molecules in order to selectively deliver the alpha emitting payloads to tumors.

Osler, Hoskin & Harcourt LLP advised Fusion Pharmaceuticals with a team consisting of Chad Bayne, Michael Grantmyre and Sahil Chopra (Emerging and High Growth Companies), Desmond Lee and Amy Sigurdson (Capital Markets), Andrew MacDougall (Corporate and Governance), Lynne Lacoursière and Kelly O'Ferrall (Executive Compensation), Shari Cohen (Employment & Labour), Tim Hughes (Tax) and Jacqueline Code (Research).


Team
Chad Bayne

Chad Bayne

Partner, Emerging and High Growth Companies

Michael Grantmyre

Michael Grantmyre

Associate, Emerging and High Growth Companies

Sahil Chopra

Sahil Chopra

Associate, Emerging and High Growth Companies

Desmond Lee

Desmond Lee

Partner, Corporate

Amy graduated from the J.D. program at Western University in 2018.

Amy Sigurdson

Associate, Corporate

Andrew MacDougall - Corporate Governance Lawyer

Andrew MacDougall

Partner, Corporate

Lynne Lacoursière - Corporate Lawyer

Lynne Lacoursière

Partner, Corporate

Kelly O’Ferrall

Kelly O’Ferrall

Counsel, Employment & Labour

Shari Cohen

Shari Cohen

Associate, Employment & Labour

Timothy  Hughes

Timothy Hughes

Partner, Taxation

Jacqueline  Code

Jacqueline Code

Partner, Research